Cancer Policy Kennedy overhauls “too woke” USPSTF with the appointment of eight membersCritics say new members will politicize, commercialize the panel September 18, 2026Vol.52 No.34By Claire Marie Porter
Cancer Policy U.S. cancer death rate declined 35% since 1991, AACR Cancer Progress Report finds September 18, 2026Vol.52 No.34
Cancer Policy Cancer centers continue to face recurring drug shortages, NCCN survey finds September 18, 2026Vol.52 No.34By Sara Willa Ernst
Cancer Policy Letai shares weekly musings in NCI’s new “Tuesdays with Tony” series September 18, 2026Vol.52 No.34
Cancer Policy FDA’s expedited IND pilot aims to shorten the timeline between drug development and first-in-human clinical trials September 18, 2026Vol.52 No.34
Cancer Policy Heidi Overton selected as FDA commissioner; Jared Seehafer named inaugural Deputy Commissioner for Technology and AI September 11, 2026Vol.52 No.33By Claire Marie Porter
Cancer Policy FDA authorizes second e-cigarette with age-gating features September 11, 2026Vol.52 No.33By Sara Willa Ernst
Cancer Policy Pentagon temporarily rescinds guidance on testosterone testing for U.S. military September 11, 2026Vol.52 No.33By Claire Marie Porter
Cancer PolicyFree Trump’s vaccine executive order draws criticism from medical community, may put cancer populations at risk August 14, 2026Vol.52 No.32By Claire Marie Porter
Cancer PolicyFree Senate passes stopgap bill that would ban OMB from finalizing rule that would politicize science August 14, 2026Vol.52 No.32By Sara Willa Ernst
